Resistance to unspecified antibiotic
ICD-10 Z16.20 is a billable code used to indicate a diagnosis of resistance to unspecified antibiotic.
Z16.20 indicates a patient's resistance to an unspecified antibiotic, which is critical in understanding the patient's health status and treatment options. Antibiotic resistance is a growing public health concern, influenced by factors such as over-prescription of antibiotics, incomplete courses of treatment, and the patient's social determinants of health, including access to healthcare, socioeconomic status, and education. Preventive care strategies, such as appropriate antibiotic stewardship and patient education on the importance of completing prescribed courses, are essential in mitigating resistance. Screening for antibiotic resistance can be integrated into routine healthcare visits, particularly for patients with recurrent infections or those in high-risk groups. Aftercare for patients with known resistance involves careful monitoring and tailored treatment plans to avoid ineffective therapies, ensuring optimal health outcomes.
Documentation should include patient history of antibiotic use, details of infections, and any previous resistance patterns.
Routine checkups where antibiotic use is discussed, screenings for recurrent infections, and aftercare for patients with known resistance.
Consideration of social determinants such as access to healthcare, education on antibiotic use, and socioeconomic factors affecting adherence.
Population-level data on antibiotic resistance, surveillance reports, and community health assessments.
Epidemiological studies tracking resistance patterns and preventive health initiatives targeting high-risk populations.
Focus on reporting and tracking health status to inform public health interventions.
Used during routine follow-up visits for patients with known antibiotic resistance.
Document patient history, current medications, and any changes in symptoms.
Primary care providers should focus on education regarding antibiotic use.
Z16.20 should be used when a patient has documented resistance to an unspecified antibiotic, particularly in the context of ongoing treatment or follow-up care. It is important to ensure that the primary diagnosis justifies the use of this Z code and that adequate documentation supports the patient's resistance history.
